Anzeige
Mehr »
Login
Montag, 05.12.2022 Börsentäglich über 12.000 News von 678 internationalen Medien
Vor Ver-10-fachung? Jetzt schon in den Lithium-Star 2023 investieren?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
238 Leser
Artikel bewerten:
(1)

Comsalud: Gynaecologists Warn That Blind Gynaecological Interventions Endanger Women's Health

MALAGA, SPAIN / ACCESSWIRE / June 2, 2022 / Gynaecologists from the HTRS Congress, involved in the diagnosis and treatment of intrauterine pathologies recommend replacing blind procedures with direct visualisation.

Comsalud, Thursday, June 2, 2022, Press release picture

Blind gynaecological diagnostic and therapeutic interventions must end in order to protect women's health and be replaced by direct visualisation techniques, as is the case in other specialties. This is the main recommendation of the international consensus carried out by leaders in gynaecology from three of the main world societies involved in these techniques: the Global Hysteroscopy Community (GCH), the American Association for Gynaecological Laparoscopy (AAGL) and the European Society for Gynaecological Endoscopy (ESGE). The consensus was presented today in Malaga during the HTRS 2022 Congress (Technological Revolution in Hysteroscopy), an event organised by the GCH, an international hysteroscopy community with more than 5,000 members.

"Blind access to the uterine cavity for the diagnosis and treatment of intrauterine pathologies is a procedure that is still very common today, and has not evolved in 150 years, entailing serious risks to women's health," explains Professor Sergio Haimovich, head of the gynaecology department at Laniado University Hospital (Netanya-Israel) and vice-chair of the AAGL Hysteroscopy section. "The use of these blind procedures puts women at risk of infection, perforation of the uterus, reoperation, injury to other organs and haemorrhage, as well as false negative biopsies," he adds.

According to a study among postmenopausal women, in women of childbearing age, up to 20.5% of focal endometrial lesions remain after blind curettage compared to 2% after hysteroscopy, forcing patients to undergo further reinterventions. Furthermore, this procedure is only able to diagnose less than half of the uterine cavity in 60% of cases, which can lead to false positives.

False negatives in cancer
"Blind curettage is frequently used in gynaecology to rule out uterine cancer, perform a biopsy or analyse the causes of abnormal uterine bleeding. However, there is increasing scientific evidence that shows how sampling is often inadequate and leads to misdiagnosis," warns Dr. Luis Alonso Pacheco, head of the Reproductive Surgery Unit at the Gutenberg centre in Malaga and former president of the Hysteroscopy section of the AAGL.

In contrast to the dangers posed to women by blind techniques, hysteroscopy is a diagnostic procedure with a complication rate of only 0.1% . In the treatment of intrauterine pathology, a review of studies by Chinese and European researchers showed that hysteroscopy is a quick procedure to remove tissue successfully and without risk of bleeding or perforation.

Contact Details

Ricardo Antonio Mariscal López
629823662
rmariscal@comsalud.es

SOURCE: Comsalud



View source version on accesswire.com:
https://www.accesswire.com/703708/Gynaecologists-Warn-That-Blind-Gynaecological-Interventions-Endanger-Womens-Health

Kostenloser Wertpapierhandel auf Smartbroker.de
© 2022 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.